ACTRN12619001112156招募中未知
The Assertive Cardiac Care Trial: A randomised controlled trial of a coproduced assertive cardiac care intervention to reduce absolute cardiovascular disease risk in people with severe mental illness in the primary care setting
niversity of Melbourne0 个研究点目标入组 504 人开始时间: 2019年8月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 504
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 35 Years 至 74 Years（—）
- 性别
- All
入选标准
- •age 35-74 years old;
- •-existing diagnosis of schizophrenia, bipolar disorder, major depression, psychosis, or other SMI identified;
- •-able to provide informed consent via a two-stage consent process involving three brief true/false questions to ensure understanding of involvement;
- •-English speaking;
- •-willing to allow the research team limited access to their participating primary health clinic (general practice) medical record.
- •- >=3% absolute cardiovascular risk (calculated at baseline Heart Health Check)
排除标准
- •-severe acute physical illness;
- •-previous CVD event;
- •-episode of acute mania or a psychosis at enrolment;
- •-pregnancy or breastfeeding;
- •-unable to provide informed consent via two stage consent;
- •- unable to understand written English or study requirements;
- •- <3% absolute cardiovascular risk (calculated at baseline Heart Health Check)
研究者
相似试验
尚未招募
不适用
Total Cardiac Care: A randomised controlled trial of a smartphone application and associated model of care in patients with cardiovascular disease.Acute coronary syndromeACTRN12618001547235Prince of Wales Hospital1,080
已完成
不适用
Cardiac Rehabilitation Program using Telemonitoring; The effects of an extended program with Telemonitoring guidance versus standard follow-up in patients after Cardiac Rehabilitatiocardiac rehabilitation, hartrevalidatie, telemonitoring, lifestyle change, telehealthNL-OMON27912Isala kliniek Zwolle, Leef en Beweegcentrum120
招募中
3 期
Effect of cardiac rehabilitation in patients undergone myocardial infarction and percutaneous coronary interventioCTRI/2019/06/019948Dr JS Thakur
已完成
2 期
Treatment of cardiac amyloid light-chain amyloidosis with the green tea compound epigallocatechin-3-galiateAmyloid light-chain amyloidosisNutritional, Metabolic, EndocrineAmyloidosisISRCTN68399350Ruprecht-Karls-University of Heidelberg (Germany)38
已完成
不适用
An Evaluation of Stepped Care for Child AnxietyAnxietyACTRN12612000351819Macquarie University250